Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gilmer

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Archives of Pediatrics & Adolescent Medicine|March 1, 1995
A comparison of educational interventions. Multimedia textbook, standard lecture, and printed textbookD M Santer, V E Michaelsen, W E Erkonen, et al.
Psychological Medicine|June 5, 2009
Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) reportA F Leuchter, M M Husain, I A Cook, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorderS Nassir Ghaemi, William S Gilmer, Robert T Dunn, et al.
The Journal of Clinical Psychiatry|January 11, 2024
Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health SystemPaul N Pfeiffer, Jamarie Geller, Dara Ganoczy, et al.
Journal of Neurosurgery|November 1, 1994
Outcome after laminectomy for lumbar spinal stenosis. Part I: Clinical correlationsG F Tuite, J D Stern, S E Doran, et al.
The Journal of Clinical Psychiatry|February 20, 2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trialIan A Cook, Aimee M Hunter, William S Gilmer, et al.
BMC Immunology|February 29, 2020
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancerAndrea J Luker, Laura J Graham, Timothy M Smith, et al.
Journal of Neurosurgery|November 1, 1994
Outcome after laminectomy for lumbar spinal stenosis. Part II: Radiographic changes and clinical correlationsG F Tuite, S E Doran, J D Stern, et al.
The Journal of Clinical Psychiatry|December 29, 2007
Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot studyS Nassir Ghaemi, William S Gilmer, Joseph F Goldberg, et al.
Psychiatry Research|August 28, 2009
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorderAndrew F Leuchter, Ian A Cook, William S Gilmer, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Archives of Pediatrics & Adolescent Medicine|March 1, 1995
A comparison of educational interventions. Multimedia textbook, standard lecture, and printed textbookD M Santer, V E Michaelsen, W E Erkonen, et al.
Psychological Medicine|June 5, 2009
Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) reportA F Leuchter, M M Husain, I A Cook, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorderS Nassir Ghaemi, William S Gilmer, Robert T Dunn, et al.
The Journal of Clinical Psychiatry|January 11, 2024
Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health SystemPaul N Pfeiffer, Jamarie Geller, Dara Ganoczy, et al.
Journal of Neurosurgery|November 1, 1994
Outcome after laminectomy for lumbar spinal stenosis. Part I: Clinical correlationsG F Tuite, J D Stern, S E Doran, et al.
The Journal of Clinical Psychiatry|February 20, 2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trialIan A Cook, Aimee M Hunter, William S Gilmer, et al.
BMC Immunology|February 29, 2020
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancerAndrea J Luker, Laura J Graham, Timothy M Smith, et al.
Journal of Neurosurgery|November 1, 1994
Outcome after laminectomy for lumbar spinal stenosis. Part II: Radiographic changes and clinical correlationsG F Tuite, S E Doran, J D Stern, et al.
The Journal of Clinical Psychiatry|December 29, 2007
Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot studyS Nassir Ghaemi, William S Gilmer, Joseph F Goldberg, et al.
Psychiatry Research|August 28, 2009
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorderAndrew F Leuchter, Ian A Cook, William S Gilmer, et al.
Pageof 5